FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On March 17, 2004
Table of Contents
Docket # Title
1975N-0183F Topical Antimicrobial Drug Products For OTC Human Use - First Aid
1975N-0183H Health-Care Antiseptic Drug Products for OTC Human Use
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
2000P-1211 Establish Mandatory Pre-Market Safety Testing for GE Foods
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2003E-0419 Iprivask, Patent Term Extension Application; U.S. Patent No. 4,745,177
2004D-0028 Draft Consumer Advisory regarding Advice for Subgroups of a Population regarding Mercury in Fish and Shellfish
2004N-0115 Prescription Drug Importation Study
2004P-0128 ANADA for clavamox (amoxicillin trihydrate/clavulanate potassium) tablets for dogs and cats
2004P-0129 Modify Current Regulation Governing Structure/function Claims, 21 CFR Pt. 101.93
2004P-0130 ANADA for AMOXI-TABS (amoxicillin) for dogs and cats
2004P-0131 ANDA Suitability for Tofin (tobramycin for Inhalation)
1975N-0183F Topical Antimicrobial Drug Products For OTC Human Use - First Aid
MM 1
Tab 1, Tabs 2-7
Alcavis International, Inc. Vol #: 8
1975N-0183H Health-Care Antiseptic Drug Products for OTC Human Use
MM 7
Tab 1,Tabs 2-7
Alcavis International, Inc. Vol #: 200
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 13293 Body Wise International, Inc. Vol #: 109
LET 13294 PhytoPharmica Natural Medicines Vol #: 109
LET 13295 Enzymatic Therapy Natural Medicines Vol #: 109
LET 13296 Enzymatic Therapy Natural Medicines Vol #: 109
LET 13297 PhytoPharmica Natural Medicines Vol #: 109
LET 13298 PhytoPharmica Natural Medicines Vol #: 109
LET 13299 PhytoPharmica Natural Medicines Vol #: 109
LET 13300 Body Wise International, Inc. Vol #: 109
LET 13301 Source Naturals Vol #: 109
LET 13302 Aboca USA, Inc. Vol #: 109
LET 13303 Aboca USA, Inc. Vol #: 109
LET 13304 Aboca USA, Inc. Vol #: 110
LET 13305 Aboca USA, Inc. Vol #: 110
LET 13306 Aboca USA, Inc. Vol #: 110
LET 13307 Aboca USA, Inc. Vol #: 110
LET 13308 Aboca USA, Inc. Vol #: 110
LET 13309 Aboca USA, Inc. Vol #: 110
LET 13310 Aboca USA, Inc. Vol #: 110
LET 13311 Aboca USA, Inc. Vol #: 110
LET 13312 Aboca USA, Inc. Vol #: 110
LET 13313 Aboca USA, Inc. Vol #: 110
LET 13314 Aboca USA, Inc. Vol #: 110
LET 13315 Aboca USA, Inc. Vol #: 110
LET 13316 Aboca USA, Inc. Vol #: 110
LET 13317 Aboca USA, Inc. Vol #: 110
LET 13318 Aboca USA, Inc. Vol #: 110
LET 13319 Your Vitamins Vol #: 110
LET 13320 Natural Organics inc. Vol #: 110
LET 13321 Natural Organics Inc. Vol #: 110
LET 13322 Natural Organics Inc. Vol #: 110
LET 13323 Your Vitamins Vol #: 110
2000P-1211 Establish Mandatory Pre-Market Safety Testing for GE Foods
C 12726 John Otterberg Vol #: 789
C 12727 Gwendolyn Attwood Vol #: 789
C 12728 Pat Tyler Vol #: 789
C 12729 Daniel Shiverly Vol #: 789
C 12730 Jennifer Medley Vol #: 789
EMC 5798 Jody Spear Vol #: 789
EMC 5799 Maya Weinstein Vol #: 789
EMC 5800 Cathy Mackey Vol #: 789
EMC 5801 Cathy Mackey Vol #: 789
EMC 5802 Cathleen Branich Vol #: 789
EMC 5803 Andrew Heydt Vol #: 789
EMC 5804 Scott Wolf Vol #: 789
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
EMC 4626 M. A. Anderews Vol #: 169
EMC 4627 N. Mans Vol #: 169
EMC 4628 E. Schulman Vol #: 169
EMC 4629 D. Pietrantonio Vol #: 169
EMC 4630 C. Weatherford Vol #: 169
EMC 4631 Lizsallen Vol #: 169
EMC 4632 P. Spray Vol #: 169
EMC 4633 J. D. Woodward Vol #: 169
EMC 4634 C. Brendler Vol #: 169
EMC 4635 k. Mossgraber Vol #: 169
EMC 4636 G. Diepenbrock Vol #: 169
EMC 4637 J. Richards Vol #: 169
EMC 4638 K. Olson Vol #: 169
EMC 4639 A. B. Mitchell Vol #: 169
EMC 4640 D. Beaton Vol #: 169
EMC 4641 K. Conrad Vol #: 169
EMC 4642 M. Shooner Vol #: 169
EMC 4643 S. Pollesch Vol #: 169
EMC 4644 K. Kelly-Hoffman Vol #: 169
EMC 4645 Debbi V. Vol #: 169
EMC 4646 R. Wrightson Vol #: 169
EMC 4647 Richard A Dilley Vol #: 169
EMC 4648 G. Brookman Vol #: 169
EMC 4649 A. Stutz Vol #: 169
EMC 4650 M. C. Nigro Vol #: 169
EMC 4651 Butterfly Vol #: 169
EMC 4652 C. Scalzo Vol #: 169
EMC 4653 C. Nordgsaard Vol #: 169
EMC 4654 B. L. Hite Vol #: 169
EMC 4655 J. MacCallum Vol #: 169
EMC 4656 K. Nesslar Vol #: 169
EMC 4657 M.L. Jackson-Miller Vol #: 169
EMC 4658 L. Farrell Vol #: 169
EMC 4659 B. Lindstrom Vol #: 169
EMC 4660 M. Leitch Vol #: 169
EMC 4661 E. Edinger Vol #: 169
EMC 4662 J. Martinez Vol #: 169
EMC 4663 M. & B. Boelling Vol #: 169
EMC 4664 W. A. White Vol #: 169
EMC 4665 S. Winner Vol #: 169
EMC 4666 G. Geoghagan Vol #: 169
EMC 4667 G. Schoerlucke Vol #: 169
EMC 4668 F. Kadagian Vol #: 169
EMC 4669 M. Stenseth Vol #: 169
EMC 4670 K. O'Grady Vol #: 169
EMC 4671 K. Phipps Vol #: 169
EMC 4672 G. Ayres Vol #: 169
EMC 4673 A. Craig Vol #: 169
EMC 4674 J. D. Janes Vol #: 169
EMC 4675 M. Wiggin Vol #: 169
EMC 4676 J. D. Janes Vol #: 169
EMC 4677 D. B. Reynolds Vol #: 169
EMC 4678 D. B. Reynolds Vol #: 169
EMC 4679 R. Vandervennet Vol #: 169
EMC 4680 M. Brister Vol #: 169
EMC 4681 H. & S. Van Asch Wyck Vol #: 169
EMC 4682 Dr. L. Pina Vol #: 169
EMC 4683 J. Markessinis Vol #: 169
EMC 4684 Rev. D. A. Ames Vol #: 169
EMC 4685 A. Glavas Vol #: 169
EMC 4686 J. Lewis Vol #: 169
EMC 4687 B. Purnell Vol #: 169
EMC 4688 M. Diamond Vol #: 169
EMC 4689 A. Warn Vol #: 169
EMC 4690 C. L. Floyd Vol #: 169
EMC 4691 R. Ryan Vol #: 169
EMC 4692 W. Brann Vol #: 169
EMC 4693 M. Holik Vol #: 169
EMC 4694 J. C. Wright Vol #: 169
EMC 4695 L. Alldrin Vol #: 169
EMC 4696 R. Burnett Vol #: 169
EMC 4697 A. Dixon Vol #: 169
EMC 4698 K. Eich Vol #: 169
EMC 4699 M. J. Battaglia Vol #: 169
EMC 4700 A. Crawford Vol #: 169
EMC 4701 S. Fremont Vol #: 169
EMC 4702 V. DeMara Vol #: 169
EMC 4703 R. Marquard Vol #: 169
EMC 4704 S. Livingston Vol #: 169
EMC 4705 K. Philipp Vol #: 169
EMC 4706 T. Buchen Vol #: 169
EMC 4707 V. Gould Vol #: 169
EMC 4708 C. Larsen Vol #: 169
EMC 4709 M. Henderson Vol #: 169
EMC 4710 Mr. Jean Rinaldo Vol #: 169
EMC 4711 D. W. Craven Vol #: 169
EMC 4712 A. Wilson Vol #: 169
EMC 4713 T. B. Zissu Vol #: 169
EMC 4714 K. Davis Vol #: 169
EMC 4715 D. Azbell Vol #: 169
EMC 4716 R. Brown Vol #: 169
EMC 4717 B. Roman Vol #: 169
EMC 4718 S. Phipps Vol #: 169
EMC 4719 F. & H. Reily Vol #: 169
EMC 4720 G. Humphrey Vol #: 169
EMC 4721 S. Pinsley Vol #: 169
EMC 4722 R. Breidenbach Vol #: 169
EMC 4723 K. Rossein Vol #: 169
EMC 4724 A. Blevins Vol #: 169
EMC 4725 S. Peskoe Vol #: 169
EMC 4726 K. Elliott Vol #: 169
EMC 4727 B. Schuler Vol #: 169
EMC 4728 T. Browne Vol #: 169
EMC 4729 M. Halonen Vol #: 169
EMC 4730 B. Winter Vol #: 169
EMC 4731 D. Rippe Vol #: 169
EMC 4732 G. McCullough Vol #: 169
EMC 4733 B. Stone Vol #: 169
EMC 4734 D. O'Donoghue Vol #: 169
EMC 4735 B. C. Reed Vol #: 169
EMC 4736 M. Savageau Vol #: 169
EMC 4737 E. Bloss Vol #: 169
2003E-0419 Iprivask, Patent Term Extension Application; U.S. Patent No. 4,745,177
N 1 FDA Vol #: 1
2004D-0028 Draft Consumer Advisory regarding Advice for Subgroups of a Population regarding Mercury in Fish and Shellfish
EMC 267 S. Mattison Vol #: 2
EMC 268 K. Paddock Vol #: 2
EMC 269 S. Theisen Vol #: 2
EMC 270 J. Moretz Vol #: 2
EMC 271 S. Morgan Vol #: 2
EMC 272 C. Costigan Vol #: 2
EMC 273 P. Chandler Vol #: 2
EMC 274 R. Mercury Vol #: 2
EMC 275 L. Catapano Vol #: 2
EMC 276 B. Scharold Vol #: 2
EMC 277 L. Catapano Vol #: 2
EMC 278 C. Hoekenga Vol #: 2
EMC 279 C. Hatcher Vol #: 2
EMC 280 S. Walker Vol #: 2
2004N-0115 Prescription Drug Importation Study
NM 1 FDA Vol #: 1
2004P-0128 ANADA for clavamox (amoxicillin trihydrate/clavulanate potassium) tablets for dogs and cats
ACK 2 Number not used Vol #: 1
2004P-0129 Modify Current Regulation Governing Structure/function Claims, 21 CFR Pt. 101.93
ACK 1 HFA-305 to American Longevity, Inc. Vol #: 1
CP 1 American Longeviry, Inc. Vol #: 1
2004P-0130 ANADA for AMOXI-TABS (amoxicillin) for dogs and cats
ACK 1 HFA-305 to Smart Drug Systems Inc. Vol #: 1
CP 1
Generic Label
Pioneer Label
Smart Drug Systems, Inc. Vol #: 1
2004P-0131 ANDA Suitability for Tofin (tobramycin for Inhalation)
ACK 1 HFA-305 to SourceCF, Inc. Vol #: 1
CP 1
Continued
SourceCF, Inc. Vol #: 1

Page created on March 17, 2004 dp
Page udpated on March 30, 2004 rc

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management